The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 23 | 49.3x | 20.1x | Below average | |
Growth | 63 | 14.8% | 5.6% | Near average | |
Quality | 84 | 56.0% | 7.6% | Above average | |
Safety | 92 | -1.7x | 0.4x | Above average | |
Capital Return | 38 | 1.33% | 2.19% | Near average | |
Momentum | — | — | — | No data | |
Sentiment | — | — | — | No data |
IRadimed Corporation is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy IRadimed Corporation shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
IRadimed stock shows a state of total stability in the target price at $120, with an absence of any price revisions during the past 7 and 30-day periods. This consistency reflects a unified optimistic view by the following analyst, as the gap between the current price and the target stands at approximately 30%, indicating expectations of strong growth despite the absence of recent updates in valuations.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.